Actavia Life Sciences Inc (RASP)
0.004
0.00 (0.00%)
USD |
OTCM |
Sep 27, 16:00
Actavia Life Sciences Shareholders Equity (Quarterly): -2.182M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -2.182M |
December 31, 2023 | -2.104M |
September 30, 2023 | -1.956M |
June 30, 2023 | -1.975M |
March 31, 2023 | -1.870M |
December 31, 2022 | -1.810M |
September 30, 2022 | -1.689M |
June 30, 2022 | -1.786M |
March 31, 2022 | -2.138M |
December 31, 2021 | -2.504M |
September 30, 2021 | -2.754M |
June 30, 2021 | -2.922M |
March 31, 2021 | -2.803M |
December 31, 2020 | -2.828M |
September 30, 2020 | -2.675M |
June 30, 2020 | -0.4045M |
March 31, 2020 | 2.278M |
December 31, 2019 | 2.426M |
September 30, 2019 | 2.537M |
June 30, 2019 | 2.527M |
March 31, 2019 | 2.660M |
Date | Value |
---|---|
December 31, 2018 | 2.833M |
September 30, 2018 | 3.106M |
June 30, 2018 | 3.430M |
March 31, 2018 | 4.161M |
December 31, 2017 | 5.039M |
June 30, 2017 | 6.660M |
March 31, 2017 | 7.551M |
December 31, 2016 | 5.773M |
September 30, 2016 | 7.887M |
June 30, 2016 | -0.0723M |
March 31, 2016 | -0.0181M |
December 31, 2015 | -0.0163M |
September 30, 2015 | -0.012M |
June 30, 2015 | -0.0101M |
March 31, 2015 | -0.008M |
December 31, 2014 | -0.0014M |
September 30, 2014 | 0.0023M |
June 30, 2014 | 0.0057M |
March 31, 2014 | 0.0206M |
December 31, 2013 | 0.0241M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-2.922M
Minimum
Jun 2021
2.537M
Maximum
Sep 2019
-1.429M
Average
-1.975M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | -0.617M |
Palatin Technologies Inc | 1.579M |
iBio Inc | 21.32M |
Theriva Biologics Inc | 27.65M |
Oragenics Inc | 1.326M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 0.0486M |
Total Liabilities (Quarterly) | 2.230M |